Respiratory biologics are booming thanks to scientists who refused to be derailed by early research setbacks
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew
With the UK’s NHS unveiling a major partnership with Amazon’s Alexa, is pharma in danger of being left behind?
Why pharma companies need to implement novel business models and more
How capturing the patient voice is unlocking medicines’ commercial potential
Good leadership is about adapting to the exceptional features of our industry
PME speaks to Richard Mason on how drug discovery is evolving
Three companies that are on the rise in biotech
The cancer immunotherapy firms ramping-up biomarker R&D
A focus on promising new research
Building on past research to learn more about the disease and how to treat it
How industry and regulators are using real-world data
Start Codon's Daniel Rooke on fostering biotech success in Cambridge, UK
Can UK-based company be first to develop a universal flu vaccine?
By Diane Wass